Thalidomide-O-amido-PEG2-C2-NH2 (TFA)
Thalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology.
Product Specifications
CAS Number
[1957235-75-4]
Product Name Alternative
Cereblon Ligand-Linker Conjugates 10 (TFA) ; E3 Ligase Ligand-Linker Conjugates 24 (TFA)
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Autophagy; E3 Ligase Ligand-Linker Conjugates
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/E3_Ligase_Ligand-Linker_Conjugates_24_TFA.html
Purity
99.72
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 150 mg/mL (ultrasonic)
Smiles
O=C(NCCOCCOCCN)COC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O.O=C(O)C(F)(F)F
Molecular Formula
C23H27F3N4O10
Molecular Weight
576.48
Precautions
H302, H315, H319, H335
References & Citations
[1]ARYL SULFONOHYDRAZIDES. WO 2017/176958 A1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Cereblon
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items